Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US.

Front Med (Lausanne) · 2025 · PMC12511141 · PMID 41080929

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

4.1 Paediatric oncology products are increasing both in the EU and in the US, but at a different pace Our results show that an increasing trend of approved oncology drugs is present both in the EU and in the US.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.